Fernic-XT Injection

Description

Iron Sucrose Injection for iron deficiency anemia, especially in CKD patients. WHO-GMP certified injectable available for pharma franchise & hospital supply.

Product Description:

Iron Sucrose Injection is a sterile intravenous iron preparation used for the treatment of iron deficiency anemia, particularly in patients who cannot tolerate or do not respond to oral iron therapy. It helps replenish iron stores, improve hemoglobin levels, and support red blood cell production.

Manufactured in WHO-GMP certified sterile facilities, this injection ensures high purity, safety, and consistent therapeutic outcomes. It is widely used in hospitals and dialysis centers, making it a high-demand product for pharma franchise injectable and critical care segments.

Key Benefits:

✔ Rapid correction of iron deficiency anemia
✔ Suitable for patients intolerant to oral iron
✔ Improves hemoglobin and iron stores effectively
✔ Well-tolerated intravenous formulation
✔ Ideal for hospital and clinical use
✔ WHO-GMP certified sterile manufacturing
✔ High demand injectable product for pharma franchise

Composition (Typical):

Iron Sucrose 100 mg / 5 ml (or as per variant)

Indications / Uses:

Iron deficiency anemia
Chronic kidney disease (CKD) associated anemia
Postpartum anemia
Pre- and post-operative anemia
Patients requiring rapid iron replenishment

Dosage Form:

Intravenous Injection
(To be administered by healthcare professional only)

Packaging:

Glass vial / ampoule
Sterile, tamper-proof packaging

Pharma Franchise Opportunity:

We offer Iron Sucrose Injection Pharma Franchise with:

✅ Monopoly franchise rights
✅ WHO-GMP certified sterile injectable manufacturing
✅ High demand hospital and dialysis product
✅ Promotional and marketing support
✅ Competitive pricing with strong profit margins

This product is a valuable addition to hematology, gynecology, and hospital pharma franchise portfolios, ensuring strong institutional demand and repeat business.